These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1092 related items for PubMed ID: 18977646

  • 1. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
    Huchon G, Magnussen H, Chuchalin A, Dymek L, Gonod FB, Bousquet J.
    Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
    [Abstract] [Full Text] [Related]

  • 2. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma.
    Papi A, Paggiaro PL, Nicolini G, Vignola AM, Fabbri LM, Inhaled Combination Asthma Treatment versus SYmbicort (ICAT SY) Study Group.
    Eur Respir J; 2007 Apr; 29(4):682-9. PubMed ID: 17107988
    [Abstract] [Full Text] [Related]

  • 3. Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler(®)) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial.
    Kanniess F, Scuri M, Vezzoli S, Francisco C, Petruzzelli S.
    Pulm Pharmacol Ther; 2015 Feb; 30():121-7. PubMed ID: 25088067
    [Abstract] [Full Text] [Related]

  • 4. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W, Levine B, Andriano K, Lavecchia C, Yegen U.
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [Abstract] [Full Text] [Related]

  • 5. Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler.
    Dhillon S, Keating GM.
    Drugs; 2006 Oct; 66(11):1475-83; discussion 1484-5. PubMed ID: 16906779
    [Abstract] [Full Text] [Related]

  • 6. Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma.
    Papi A, Paggiaro P, Nicolini G, Vignola AM, Fabbri LM, ICAT SE study group.
    Allergy; 2007 Oct; 62(10):1182-8. PubMed ID: 17845589
    [Abstract] [Full Text] [Related]

  • 7. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D, Vicaut E, Lefrançois G, Formoterol HFA group.
    Respiration; 2005 Oct; 72 Suppl 1():20-7. PubMed ID: 15915009
    [Abstract] [Full Text] [Related]

  • 8. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A, Corradi M, Pigeon-Francisco C, Baronio R, Siergiejko Z, Petruzzelli S, Fabbri LM, Rabe KF.
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [Abstract] [Full Text] [Related]

  • 9. Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status.
    Brusselle G, Peché R, Van den Brande P, Verhulst A, Hollanders W, Bruhwyler J.
    Respir Med; 2012 Jun; 106(6):811-9. PubMed ID: 22357130
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
    Drugs; 2006 Jun; 66(17):2235-54. PubMed ID: 17137405
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence study.
    Morice AH, Peterson S, Beckman O, Kukova Z.
    Pulm Pharmacol Ther; 2008 Jun; 21(1):152-9. PubMed ID: 17376722
    [Abstract] [Full Text] [Related]

  • 12. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE, Noonan MJ.
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [Abstract] [Full Text] [Related]

  • 13. Comparison of extrafine beclomethasone dipropionate/formoterol fumarate dry powder inhaler and pressurized metered-dose inhaler in Chinese patients with asthma: the FORTUNE study.
    Zheng J, Zhang J, Fu X, Lin C, Zhang X, Mei X, Corradi M, Cappellini G, Calabro E, Zhu C, Topole E.
    J Asthma; 2024 Apr; 61(4):360-367. PubMed ID: 37878325
    [Abstract] [Full Text] [Related]

  • 14. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler.
    Chervinsky P, Baker J, Bensch G, Parasuraman B, Boggs R, Martin P, O'Dowd L.
    Ann Allergy Asthma Immunol; 2008 Nov; 101(5):463-73. PubMed ID: 19055199
    [Abstract] [Full Text] [Related]

  • 15. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.
    Papi A, Canonica GW, Maestrelli P, Paggiaro P, Olivieri D, Pozzi E, Crimi N, Vignola AM, Morelli P, Nicolini G, Fabbri LM, BEST Study Group.
    N Engl J Med; 2007 May 17; 356(20):2040-52. PubMed ID: 17507703
    [Abstract] [Full Text] [Related]

  • 16. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
    Bousquet J, Huchon G, Leclerc V, Vicaut E, Lefrançois G.
    Respiration; 2005 May 17; 72 Suppl 1():6-12. PubMed ID: 15915007
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
    Molimard M, Guenolé E, Duvauchelle T, Vicaut E, Lefrançois G.
    Respiration; 2005 May 17; 72 Suppl 1():28-34. PubMed ID: 15915010
    [Abstract] [Full Text] [Related]

  • 18. Beclomethasone/formoterol in the management of COPD: a randomised controlled trial.
    Calverley PM, Kuna P, Monsó E, Costantini M, Petruzzelli S, Sergio F, Varoli G, Papi A, Brusasco V.
    Respir Med; 2010 Dec 17; 104(12):1858-68. PubMed ID: 20965712
    [Abstract] [Full Text] [Related]

  • 19. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
    Murphy K, Nelson H, Parasuraman B, Boggs R, Miller C, O'Dowd L.
    Curr Med Res Opin; 2008 Mar 17; 24(3):879-94. PubMed ID: 18267051
    [Abstract] [Full Text] [Related]

  • 20. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr 17; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.